XOM
50
-4
VRTX
73
7
BK
75
-2
MAT
72
3
NOC
61
-9
APH
56
-5
GRMN
42
2
ETN
48
-9
AMGN
52
3
CL
32
-11
ETR
49
-8
COF
68
-2
VRSK
32
-5
UNP
46
-7
AEP
62
-4
AVGO
40
-19
GD
67
-6
ADM
59
-8
GOOGL
51
3
WDC
65
-4
XOM
50
-4
VRTX
73
7
BK
75
-2
MAT
72
3
NOC
61
-9
APH
56
-5
GRMN
42
2
ETN
48
-9
AMGN
52
3
CL
32
-11
ETR
49
-8
COF
68
-2
VRSK
32
-5
UNP
46
-7
AEP
62
-4
AVGO
40
-19
GD
67
-6
ADM
59
-8
GOOGL
51
3
WDC
65
-4
Financhill
Back

YieldMax Short TSLA Option Income Strategy ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
40

CRSH
YieldMax Short TSLA Option Income Strategy ETF

Last Price:
$25.97
Seasonality Move:
-15.4%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
40
YieldMax Short TSLA Option Income Strategy ETF (CRSH) is a Sell

Is YieldMax Short TSLA Option Income Strategy ETF a Buy, Sell or Hold?

  • The current YieldMax Short TSLA Option Income Strategy ETF [CRSH] share price is $25.95. The Score for CRSH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CRSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSH Stock Price Chart

What is YieldMax Short TSLA Option Income Strategy ETF's stock price today?

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

CRSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: -23824 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.89 - 26.83) Buy
Bollinger Bands (100): (25.99 - 35.93) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

CRSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.76 Buy
20-day SMA: 25.59 Buy
50-day SMA: 27.47 Sell
200-day SMA: 42.3 Sell
8-day EMA: 25.81 Buy
20-day EMA: 25.97 Sell
50-day EMA: 27.68 Sell
200-day EMA: 46.41 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

YieldMax Short TSLA Option Income Strategy ETF Earnings Growth & CRSH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

YieldMax Short TSLA Option Income Strategy ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):